Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.45 |
| ▸ | PDK2 | Q15119 | 5/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.33 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7053703 | 0.87 | ESR1 (0.56) | LMNANPSR1ESR1ESR2PDK2 | |
| SCHEMBL19020415 | 0.85 | MEN1 (0.48) | LMNANPSR1ESR1ESR2PDK2 | |
| SCHEMBL1167923 | 0.85 | MEN1 (0.48) | LMNANPSR1ESR1ESR2PDK2 | |
| SCHEMBL20999033 | 0.85 | LMNA (0.41) | LMNANPSR1ESR1ESR2PDK2 | |
| SCHEMBL15966167 | 0.84 | ESR1 (0.47) | LMNANPSR1ESR1ESR2PDK2 | |
| SCHEMBL28500082 | 0.82 | MEN1 (0.50) | LMNANPSR1ESR1ESR2PDK2 | |
| SCHEMBL21258346 | 0.81 | NPSR1 (0.48) | LMNANPSR1ESR1ESR2PDK2 | |
| SCHEMBL20707239 | 0.81 | LMNA (0.40) | LMNANPSR1ESR1ESR2PDK2 | |
| SCHEMBL12978440 | 0.81 | ESR1 (0.43) | LMNANPSR1ESR1ESR2PDK2 | |
| SCHEMBL15218716 | 0.80 | KMO (0.44) | LMNANPSR1ESR1ESR2PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228523-A1 | Metal complexes | UDC IRELAND LTD (IE) | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228523-A1 | Metal complexes | MCU, IMMT, SOD1 | LMNA 4738/4885NPSR1 1982/4885ESR1 1322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.